Intellia Therapeutics, Inc. (NTLA)

Intellia Therapeutics Revenue

Intellia Therapeutics had revenue of $16.63M in the quarter ending March 31, 2025, a decrease of -42.54%. This brings the company's revenue in the last twelve months to $45.57M, down -13.37% year-over-year. In the year 2024, Intellia Therapeutics had annual revenue of $57.88M with 59.55% growth.

• Revenue (ttm): $45.57M
• Revenue Growth: -13.37%
• P/S Ratio: 17.97
• Revenue / Employee: $113,074
• Employees: 403
• Market Cap: 840.56M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	57.88M	21.60M	59.55%
Dec 31, 2023	36.28M	-15.85M	-30.40%
Dec 31, 2022	52.12M	19.07M	57.69%
Dec 31, 2021	33.05M	-24.94M	-43.01%
Dec 31, 2020	57.99M	14.89M	34.55%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.